Pfizer, German institute wrangle over effectiveness of Lipitor

09/6/2005 | MarketWatch

Pfizer Deutschland, Pfizer's German unit, took issues with a study released over the weekend saying Lipitor was no more effective than other statins and caused worse side effects in some cases. An independent German institute issued the report, but Pfizer insisted its drug had fewer side effects than other cardiovascular drugs.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN